Related Experiment Video

Updated: Jun 18, 2026

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

Connective tissue growth factor-(CTGF, CCN2)--a marker, mediator and therapeutic target for renal fibrosis

Mysore K Phanish1, S K Winn, M E C Dockrell

  • 1SW Thames Institute for Renal Research, St. Helier Hospital, London, UK. mysore.phanish@esth.nhs.uk

Nephron. Experimental Nephrology
|December 4, 2009
PubMed

Insights

Connective tissue growth factor (CTGF, CCN2) drives kidney fibrosis. Targeting CCN2 offers a promising therapeutic strategy for treating progressive kidney diseases and renal fibrosis.

Area of Science:

  • Nephrology
  • Fibrosis Research
  • Molecular Biology

Background:

  • Connective tissue growth factor (CTGF, also known as CCN2) is a critical mediator of tissue fibrosis.
  • CCN2 is implicated in the pathogenesis of glomerular and tubulointerstitial fibrosis in progressive kidney diseases.

Purpose of the Study:

  • To review the biological functions of CCN2.
  • To discuss the regulation of the CCN2 gene and its cellular mechanisms in promoting fibrosis.
  • To examine the evidence for CCN2's role in renal fibrosis and its therapeutic potential.

Main Methods:

  • Literature review of existing in vivo and in vitro studies.
  • Analysis of CCN2 gene regulation and cellular signaling pathways.
  • Evaluation of therapeutic strategies targeting CCN2.

Main Results:

  • CCN2 is a key driver of renal fibrosis through complex cellular mechanisms.
  • Evidence supports CCN2's significant role in the development of kidney fibrosis.
  • Targeting CCN2 presents a viable therapeutic avenue for renal fibrosis.

Conclusions:

  • CCN2 is a central player in the development of renal fibrosis.
  • Understanding CCN2 biology is crucial for developing effective treatments for kidney disease.
  • Therapeutic inhibition of CCN2 holds promise for managing progressive kidney diseases.

More Related Videos

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel08:23

Fabricating a Kidney Cortex Extracellular Matrix-Derived Hydrogel

Published on: October 13, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Healing I: Introduction01:11

Healing I: Introduction

Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...